Control Bionics Limited (ASX:CBL)
Australia · Delayed Price · Currency is AUD 0.0620
+0.0020 (3.33%)
Sep 18, 2026, 12:05 PM AEST
Control Bionics Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 2.08 | 0.59 | 0.98 | 0.94 | 5.21 |
Short-Term Investments | 0.08 | 0.08 | 0.08 | 0.06 | 0.06 |
Cash & Short-Term Investments | 2.15 | 0.67 | 1.06 | 0.99 | 5.27 |
Cash Growth | 220.34% | -36.46% | 6.76% | -81.18% | -57.31% |
Accounts Receivable | 0.78 | 1.4 | 1.28 | 1.31 | 1.17 |
Other Receivables | 0.49 | 0.49 | 0.83 | 0.45 | 0.31 |
Receivables | 1.27 | 1.89 | 2.11 | 1.95 | 2.19 |
Inventory | 0.45 | 0.41 | 0.4 | 0.8 | 0.92 |
Prepaid Expenses | - | - | - | 0.15 | 0.22 |
Other Current Assets | 0.3 | 0.2 | 0.19 | - | - |
Total Current Assets | 4.18 | 3.17 | 3.76 | 3.9 | 8.61 |
Property, Plant & Equipment | 0.36 | 0.84 | 1.22 | 0.72 | 0.73 |
Long-Term Investments | - | 0.34 | - | - | - |
Goodwill | 0.75 | - | - | - | - |
Other Intangible Assets | 3.76 | 3.88 | 4.05 | 4.11 | 4.07 |
Other Long-Term Assets | - | - | - | - | 0.02 |
Total Assets | 9.05 | 8.23 | 9.03 | 8.73 | 13.44 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 1.44 | 1.39 | 1.02 | 0.69 | 0.43 |
Accrued Expenses | 0.56 | 0.59 | 0.44 | 0.53 | 0.62 |
Short-Term Debt | 0.49 | 0.09 | 0.52 | - | 0.05 |
Current Portion of Leases | 0.13 | 0.21 | 0.11 | 0.13 | 0.11 |
Current Unearned Revenue | 0.1 | 0.27 | 0.32 | 0.22 | 0.15 |
Total Current Liabilities | 2.72 | 2.55 | 2.4 | 1.56 | 1.36 |
Long-Term Leases | - | 0.13 | 0.34 | - | 0.12 |
Pension & Post-Retirement Benefits | 0.02 | 0.04 | 0.02 | 0.02 | 0.03 |
Total Liabilities | 2.73 | 2.72 | 2.76 | 1.58 | 1.51 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 48.39 | 40.37 | 35.15 | 30.24 | 29.27 |
Retained Earnings | -42.65 | -35.39 | -29.28 | -23.37 | -17.73 |
Comprehensive Income & Other | 0.58 | 0.53 | 0.39 | 0.27 | 0.39 |
Shareholders' Equity | 6.31 | 5.51 | 6.27 | 7.15 | 11.92 |
Total Liabilities & Equity | 9.05 | 8.23 | 9.03 | 8.73 | 13.44 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 0.62 | 0.44 | 0.96 | 0.13 | 0.28 |
Net Cash (Debt) | 1.54 | 0.24 | 0.1 | 0.86 | 4.99 |
Net Cash Growth | 547.34% | 144.73% | -88.77% | -82.69% | -59.56% |
Net Cash Per Share | 0.00 | 0.00 | 0.00 | 0.01 | 0.06 |
Filing Date Shares Outstanding | 543.09 | 294.61 | 199.29 | 102.41 | 90.48 |
Total Common Shares Outstanding | 411.96 | 294.61 | 199.29 | 90.48 | 86.91 |
Working Capital | 1.47 | 0.62 | 1.36 | 2.34 | 7.25 |
Book Value Per Share | 0.02 | 0.02 | 0.03 | 0.08 | 0.14 |
Tangible Book Value | 1.81 | 1.63 | 2.22 | 3.04 | 7.85 |
Tangible Book Value Per Share | 0.00 | 0.01 | 0.01 | 0.03 | 0.09 |
Machinery | 1.63 | 1.8 | 1.87 | 1.4 | 1.06 |
Construction In Progress | - | 0 | - | 0 | 0.05 |
Leasehold Improvements | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |